USPTO serial 87392124
Q
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 6, 2021
- Examiner
- MAYES, LAURIE ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Q?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J. Bunton
Donna J. Bunton NIXON & VANDERHYE P.C.901 NORTH GLEBE ROAD, 11TH FLOORARLINGTON, VA 22203UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific or research use; diagnostic reagents for scientific or research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations for scientific purposes, other than for medical or veterinary use; diagnostic preparations for scientific or research use other than for medical use; nucleic acids for laboratory use; nucleic acid for use in nucleic acid amplification processes other than for medical and veterinary use; nucleic acid amplification reagents other than for medical and veterinary use; nucleic acid sequencing programs other than for medical and veterinary use; nucleic acid sequences, other than for medical or veterinary purposes; chemicals for use in multiplying nucleic acid amounts other than medical and veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; diagnostic preparations for scientific purposes; chemical products for scientific diagnostic use; chemical diagnostic reagents for industrial use; diagnostic preparations, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Nucleic acid sequences for medical and veterinary purposes; diagnostic preparations for veterinary purposes; medical diagnostic reagents; clinical diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical purposes | ACTIVE | — |
| 009 | Scientific apparatus for detecting, identifying and analyzing pathogens and infectious agents, and for microbial identification and antibiotic resistance marker mapping, all the aforesaid, for laboratory or medical research purposes; Scientific instruments for microbial identification and antibiotic resistance marker mapping; laboratory instruments for the detection of pathogens and toxins in a biological sample for research use; diagnostic apparatus, not for medical purposes, for the detection and identification of pathogens for laboratory or research purposes; software for use in protein and nucleic acid analysis, micro-organism detection and identification, and in vitro diagnostics; computer operating systems; detection apparatus, namely, medical laboratory research apparatus for detecting pathogens or infectious agents; diagnostic apparatus, namely, fluorescence detectors; measuring instruments for measuring and quantifying DNA sequences; measuring apparatus for measuring and quantifying DNA sequences; testing apparatus for diagnostic purposes other than medical and veterinary use, namely, apparatus for testing antibiotic susceptibility of pathogens | ACTIVE | — |
| 010 | Diagnostic apparatus for the detection of abnormal prion protein for medical use for the detection of cancer; medical apparatus, namely, testing apparatus for analyzing bacteria in biological samples for medical use; medical diagnostic instruments for the detection and identification of pathogens or infectious agents; diagnostic apparatus for the detection and identification of pathogens or infectious agents for medical use; testing instruments for medical diagnostic purposes, for testing blood and other bodily fluids and biological samples; testing apparatus for testing blood and other bodily fluids and biological samples for medical and veterinary use | ACTIVE | — |
| 042 | Scientific analysis in the field of molecular biology; scientific research relating to molecular sciences; technological scientific research relating to protein and nucleic acid analysis, micro-organism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, the antibiotic susceptibility of pathogens, microbial identification and antibiotic resistance marker mapping; technological scientific studies relating to protein and nucleic acid analysis, micro-organism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, the antibiotic susceptibility of pathogens, microbial identification and antibiotic resistance marker mapping; technological scientific consultancy relating to protein and nucleic acid analysis, micro-organism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, the antibiotic susceptibility of pathogens, microbial identification and antibiotic resistance marker mapping; scientific and scientific technological services, namely, protein and nucleic acid analysis, micro-organism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, analyzing and testing the antibiotic susceptibility of pathogens, microbial identification, and antibiotic resistance marker mapping; scientific consultancy and research services in the fields of science, engineering and information technology; provision of scientific information and data relating to scientific and technological research and development; research and development services in the field of bacteriology, cytology, antibody technology, chemistry, immunology and gene expression systems; scientific research; scientific consultancy relating to dietary supplements; scientific analysis in the field of molecular biology; scientific research services; scientific laboratory services; scientific genetic testing for scientific research purposes; scientific advisory services relating to carbon offsetting; compilation of scientific information; preparation of scientific reports for scientific analysis purposes; scientific research and development; conducting of scientific studies in the field of medicine; providing laboratory research services featuring the conducting of scientific experiments relating to pharmaceuticals; scientific research relating to bacteriology; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; design and development of diagnostic apparatus; research and development in the field of diagnostic preparations; biotechnology testing relating to DNA, for scientific research purposes; microbiological testing for scientific research purposes; bacteriological research and testing for scientific research purposes; analytical services relating to the testing of the bacterial content of liquids for scientific research purposes; medical testing for research purposes | ACTIVE | — |
| 044 | Rental of apparatus and installations in the field of medical technology, namely, rental of medical equipment; consultancy services in the fields of medical and orthopedic surgery; medical diagnostic testing, monitoring and reporting services; surgical diagnostic services in the nature of exploratory surgery services for use in diagnosing medical illness and conditions; medical testing for diagnostic and treatment purposes, medical services for the testing of blood; medical services for the testing of sera; medical and healthcare services in the fields of DNA, genetics and genetic testing; medical testing services relating to the diagnosis and treatment of disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Q-linea AB
- Other trademarks owned by Q-linea AB
- Other trademarks owned by Q-linea AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named Q
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 6, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 31, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 15, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 8, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 8, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 8, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 8, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 23, 2021 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 29, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 3, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 3, 2020 | ALIE | ASSIGNED TO LIE | — |
| Dec 3, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 3, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 3, 2020 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Dec 3, 2020 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Nov 24, 2020 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Nov 24, 2020 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Nov 24, 2020 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 30, 2020 | TPAD | TEAS PETITION TO AMEND BASIS RECEIVED | — |
| Jul 22, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 21, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 21, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 1, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 1, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 30, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 30, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 30, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 11, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 11, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 11, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 2, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 31, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 31, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 3, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 29, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 29, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 29, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 6, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 12, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 12, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 22, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 4, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |